Use Of Il-33 Antagonists To Treat Fibrotic Disease

Patent No. EP2475388 (titled "Use Of Il-33 Antagonists To Treat Fibrotic Disease") was filed by Merck Sharp & Dohme on Sep 1, 2010. The application was issued on Nov 8, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELI LILLYAug 8, 2018KENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2475388

MERCK SHARP & DOHME
Application Number
EP10815921A
Filing Date
Sep 1, 2010
Status
Opposition Rejected
Mar 27, 2020
Publication Date
Nov 8, 2017